Gene · 57045
TWSG1: twisted gastrulation BMP signaling modulator 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. TWSG1: twisted gastrulation BMP signaling modulator 1. Genes, record 57045. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/57045
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9GZX9 | Twisted gastrulation protein homolog 1 | 223 | 6 | Ensembl, GeneID, HGNC |
Source UniProt
Patents43
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 68755 | Q9GZX9 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 2014 | Q9GZX9 | Espacenet |
| US 12458693 B2 | 2025-11-04 | 1238 | Q9GZX9 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 13825 | Q9GZX9 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 7985 | Q9GZX9 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 7985 | Q9GZX9 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 2014 | Q9GZX9 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 13825 | Q9GZX9 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 13825 | Q9GZX9 | Espacenet |
| US 12145970 B2 | 2024-11-19 | 1 | Q9GZX9 | Espacenet |
1 to 10 of 43
See all 43 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants982
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | TWSG1 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 15 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 12 | 2025 |
| P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 7 | 2025 |
| R01CA097098 | Targeting the MUC1-C Oncoprotein in Triple-Negative Breast Cancer | 7 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 5 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 5 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 5 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 3 | 2025 |
| P30CA015704 | Cancer Center Support Grant | 3 | 2025 |
| P30CA016056 | Roswell Park Cancer Center Support Grant | 3 | 2025 |
1 to 10 of 982Source NIH's project files
See all 982 nih grantsPapers1,736
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical and Molecular Profiles of Treatment-Emergent Small Cell Neuroendocrine Prostate Cancers in the Era of Intensified Systemic Therapies. | Cancer Res Commun | 2026 | 42809709 | PubTator, text mining | PubMed |
| Distinct mutational landscapes for germline and somatic cancer variants in forty tumor suppressor genes. | Am J Hum Genet | 2026 | 42641600 | PubTator, text mining | PubMed |
| Whole-genome resequencing with multidimensional annotation revealed pathogenic networks in sirenomelia. | Ital J Pediatr | 2026 | 42601645 | PubTator, text mining | PubMed |
| A multi-omics framework integrating gut microbiota, blood metabolites, and immune cells to elucidate the pathogenesis of Alzheimer's disease. | Front Immunol | 2026 | 42519311 | PubTator, text mining | PubMed |
| Anatomical Variability of the Transverse and Sigmoid Sinus Grooves: Implications for Skull Base Surgery. | J Neurol Surg B Skull Base | 2026 | 42404197 | PubTator, text mining | PubMed |
| Functional interaction between miR-505-3p and miR-21 contributes to GBM suppression. | Sci Rep | 2026 | 42350583 | PubTator, text mining | PubMed |
| Structural and biophysical analysis of the four CHRD domains of human chordin reveals a novel binding site for glycosaminoglycans. | J Biol Chem | 2026 | 42285510 | PubTator, text mining | PubMed |
| Precision Diagnostics in Prostate Cancer Treatment (PREDICT): A Phase II Multiarm Biomarker-Based Study (Alliance A032102). | JCO Oncol Adv | 2026 | 42232816 | PubTator, text mining | PubMed |
| Programmable Circular Single-Stranded DNA Acts as Recyclable Anti-miRNA Nucleotides to Inhibit Colorectal Cancer. | Small Methods | 2026 | 42126145 | PubTator, text mining | PubMed |
| A conserved re-epithelialization program underlies malignancy in pancreatic ductal adenocarcinoma. | Cancer Cell | 2026 | 42066759 | PubTator, text mining | PubMed |
1 to 10 of 1,736
See all 1,736 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/57045
GET https://conductscience.org/api/genes/v1/57045/patents?page=2